Concepedia

KEYNOTE-024: Pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) as first-line therapy for advanced NSCLC with a PD-L1 tumor proportion score (TPS) ≥50%

Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, András Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe,

Annals of Oncology · 2016 · 17 citations · 0 references

Open access

Concepts

MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMedical OncologyCytotoxic ChemotherapyTargeted Cancer TherapyTargeted TherapyToxicity ManagementPd-l1 BlockadePembrolizumab TherapyPlatinum-based AgentsPlatinum-based RegimensProgrammed Death-ligand 1 Biomarker